CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Insider Changes in Ownership
- 10-K/A Report 10-K/A
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Acquisition or sale completed · Other events
- 10-K Report Annual Report
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- SC 13G/A Stake Amended Statement of Ownership
- S-3/A Offering Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 4/A Insider Changes in Ownership
- 3/A Insider 3/A
- 4/A Insider Changes in Ownership
- 3/A Insider 3/A
Page 64 of 74 · 1,467 filings